Raymond James Financial Inc Reviva Pharmaceuticals Holdings, Inc. Transaction History
Raymond James Financial Inc
- $258 Billion
- Q1 2025
A detailed history of Raymond James Financial Inc transactions in Reviva Pharmaceuticals Holdings, Inc. stock. As of the latest transaction made, Raymond James Financial Inc holds 15,134 shares of RVPH stock, worth $6,204. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,134
Previous 14,000
8.1%
Holding current value
$6,204
Previous $24,000
41.67%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding RVPH
# of Institutions
59Shares Held
7.74MCall Options Held
938KPut Options Held
40.8K-
Vanguard Group Inc Valley Forge, PA1.8MShares$739,6770.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.53MShares$629,0690.0% of portfolio
-
Diadema Partners LP Morristown, NJ651KShares$266,7960.16% of portfolio
-
Persistent Asset Partners LTD Hong Kong, K3641KShares$262,8810.18% of portfolio
-
Tang Capital Management LLC San Diego, CA510KShares$209,2340.03% of portfolio
About REVIVA PHARMACEUTICALS HOLDINGS, INC.
- Ticker RVPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,442,900
- Market Cap $8.38M
- Description
- Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is RP506...